GolfN | $1,300,000 | (Jun 27, 2024)
Form Health | $38,000,000 | (Jun 27, 2024)
RISR | $1,500,000 | (Jun 27, 2024)
Certified by Founder
Lodge
HI-Bio
start up
United States
- South San Francisco, California
- 05/01/2024
- Series B
- $95,000,000
Human Immunology Biosciences (HI-Bio) is leading clinical immunology into its next chapter with therapies that target cellular drivers of disease. HI-Bio uses a precision medicine approach to deliver therapies for patients with the auto-immune, allergic and inflammatory diseases that can together be referred to as immune-mediated diseases (IMDs).
- Industry Biotechnology Research
- Website https://hibio.com/
- LinkedIn https://www.linkedin.com/company/hibio/about/
Onehouse | $35,000,000 | (Jun 27, 2024)
Carelane | $855,032 | (Jun 27, 2024)
Ario | $16,000,000 | (Jun 27, 2024)
Wave Photonics | $5,689,170 | (Jun 27, 2024)
Datachamps | $500,000 | (Jun 27, 2024)
Formation Bio | $327,000,000 | (Jun 27, 2024)
LunchTable | $2,400,000 | (Jun 27, 2024)
Care Hires | $2,148,528 | (Jun 27, 2024)
iVerify | $12,000,000 | (Jun 27, 2024)